The government of the Republic of China is determined that its new, NT$5.1 billion ($194.6 million) national health Insurance program will be implemented in January, even if the enabling organizational regulation of the National Health Insurance Bureau has not been passed in the Legislative Yuan by the end of this month.
Government ministers have said that the Legislative and the Executive Yuans will work together as intensely as they can to get the legislation through, but whatever happens, insurance identification cards would be issued to the public at the end of November and beginning of December. Up to 19 million residents will be covered by the program by the end of the year, said the government.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze